Results
Piramal Pharma Q4 Net Profit Dips 5.6% YoY
• Board approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026, reporting FY net profit of ₹700.01 crore.
• Reappointed four directors including Executive Ch
